Vaccines aplenty
- 1 October 2002
- journal article
- tropical and-travel-associated-diseases
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 15 (5) , 461-463
- https://doi.org/10.1097/00001432-200210000-00001
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in MonkeysJournal of Virology, 2002
- Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infectionsVaccine, 2002
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.The American Journal of Tropical Medicine and Hygiene, 2001
- Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.The American Journal of Tropical Medicine and Hygiene, 2001
- Efficacy of single-dose SA 14–14–2 vaccine against Japanese encephalitis: a case control studyThe Lancet, 2001
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus VaccineJournal of Virology, 2000
- Live attenuated tetravalent dengue vaccineVaccine, 2000
- New initiatives for the control of Japanese encephalitis by vaccination:Vaccine, 2000
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988